REGENXBIO enhances and expands scientific leadership
REGENXBIO announced that Olivier Danos, Ph.D., is joining REGENXBIO in the newly created position of CSO. Dr. Danos joins REGENXBIO from Biogen Inc., where he was Senior Vice President, Cell and Gene Therapy. March 28, 2017